WATSON DAVID O. (General Counsel) received a stock award from APELLIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/30/2026ACC: 0001492422-26-000072
Officer· General Counsel
Since Sep 2018
+55.99K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
55.99K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+55.99K
Price / share
—
Trade value
—
% of position
63.2%
1/28/2026
88.53K→144.52K
Total
Net shares
+55.99K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/28/2026 | A · Award | +55.99K | — | — | 63.2% | 88.53K | 144.52K |
| Total | +55.99K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned10K
Common Stock
IndirectShares owned0.00
Common Stock
IndirectShares owned50.14K
Total
60.14K indirect60.14K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10K | Indirect |
| Common Stock | 0.00 | Indirect |
| Common Stock | 50.14K | Indirect |
| Total | 60.14K | 60.14K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported